Tezspire vs Advair Diskus
A side-by-side look at two respiratory medications advertised on TV. Informational only — not medical advice.
| US Tezspire | US Advair Diskus | |
|---|---|---|
| Generic name | tezepelumab | fluticasone/salmeterol |
| Drug class | TSLP Blocker (Biologic) | Inhaled Corticosteroid / LABA Combination |
| Treats | Severe asthma | Asthma and COPD |
| Category | Respiratory | Respiratory |
| Manufacturer | Amgen/AstraZeneca | GSK |
| Year approved | 2021 | 2000 |
| FDA warning | No boxed warning | Moderate warnings |
| Est. TV ad spend | $70M | — |
| Common side effects | Sore throat, Joint pain, Back pain, Injection site reactions | Thrush (mouth infection), Hoarse voice, Headache, Throat irritation |
Advair Diskus
Frequently asked questions
Is Tezspire or Advair Diskus better?
Neither is universally "better." Tezspire (tezepelumab) and Advair Diskus (fluticasone/salmeterol) are both used for respiratory, but the right choice depends on your medical history, insurance and your doctor's guidance. This comparison is informational only.
What's the difference between Tezspire and Advair Diskus?
Tezspire is a TSLP Blocker (Biologic) made by Amgen/AstraZeneca, while Advair Diskus is a Inhaled Corticosteroid / LABA Combination made by GSK. See the table above for a side-by-side breakdown.
Which one spends more on TV ads?
Tezspire has the larger estimated TV advertising budget of the two.